Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ITGR Integer	$121.33 +0.0%	$120.51	$104.93 ▼ $146.36	$4.23B	0.98	384,827 shs	419,886 shs
MASI Masimo	$171.34 +1.4%	$161.71	$101.61 ▼ $194.88	$9.16B	1.19	637,733 shs	431,836 shs
NUVA NuVasive	$39.75	$39.64	$35.17 ▼ $49.53	$2.08B	1.07	1.16 million shs	N/A
TFX Teleflex	$121.40 -0.4%	$123.76	$115.94 ▼ $249.91	$5.38B	1.08	630,347 shs	532,467 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ITGR Integer	-0.10%	+0.53%	+3.09%	+4.50%	+4.82%
MASI Masimo	+1.38%	+1.20%	+3.82%	+12.45%	+51.07%
NUVA NuVasive	0.00%	0.00%	0.00%	0.00%	0.00%
TFX Teleflex	-0.08%	+1.77%	+1.46%	-12.03%	-42.49%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ITGR Integer	3.598 of 5 stars	3.5	4.0	0.0	0.0	1.1	2.5	1.9
MASI Masimo	4.2186 of 5 stars	3.4	1.0	0.0	4.2	2.1	2.5	1.3
NUVA NuVasive	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	4.6863 of 5 stars	3.0	4.0	2.5	3.9	2.4	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ITGR Integer	3.00	Buy	$145.00	19.51% Upside
MASI Masimo	2.83	Moderate Buy	$191.60	11.82% Upside
NUVA NuVasive	0.00	N/A	N/A	N/A
TFX Teleflex	2.09	Hold	$164.63	35.61% Upside

Current Analyst Ratings Breakdown

Latest NUVA, MASI, TFX, and ITGR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/22/2025	ITGR Integer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy	$133.00 ➝ $140.00
5/7/2025	MASI Masimo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$193.00
5/7/2025	MASI Masimo	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$215.00 ➝ $200.00
5/7/2025	MASI Masimo	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$204.00 ➝ $185.00
5/7/2025	MASI Masimo	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $190.00
5/5/2025	TFX Teleflex	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$140.00 ➝ $137.00
5/5/2025	TFX Teleflex	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$191.00 ➝ $173.00
5/2/2025	TFX Teleflex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$150.00 ➝ $145.00
5/2/2025	TFX Teleflex	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$146.00 ➝ $137.00
4/25/2025	ITGR Integer	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$140.00 ➝ $150.00
4/25/2025	ITGR Integer	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$145.00 ➝ $150.00

(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ITGR Integer	$1.72B	2.47	$8.91 per share	13.62	$48.27 per share	2.51
MASI Masimo	$2.09B	4.44	$6.48 per share	26.46	$19.50 per share	8.79
NUVA NuVasive	$1.23B	1.70	$4.96 per share	8.01	$17.02 per share	2.34
TFX Teleflex	$3.05B	1.76	$25.29 per share	4.80	$92.11 per share	1.32

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ITGR Integer	$119.90M	$2.11	57.50	18.25	1.04	4.38%	11.95%	6.04%	7/24/2025 (Estimated)
MASI Masimo	-$304.90M	-$9.17	N/A	37.01	N/A	-25.06%	22.56%	10.00%	8/5/2025 (Estimated)
NUVA NuVasive	$40.41M	$0.50	79.50	15.35	N/A	2.32%	12.17%	4.88%	N/A
TFX Teleflex	$69.68M	$3.17	38.30	8.00	1.91	4.96%	14.73%	8.79%	7/30/2025 (Estimated)

Latest NUVA, MASI, TFX, and ITGR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/24/2025	Q2 2025	ITGR Integer	$1.57	N/A	N/A	N/A	$464.37 million	N/A
5/6/2025	Q1 2025	MASI Masimo	$1.24	$1.36	+$0.12	-$3.12	$367.79 million	$372.00 million
5/1/2025	Q1 2025	TFX Teleflex	$2.88	$2.91	+$0.03	$2.07	$699.37 million	$700.67 million
4/24/2025	Q1 2025	ITGR Integer	$1.27	$1.31	+$0.04	-$0.66	$428.51 million	$437.39 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ITGR Integer	N/A	N/A	N/A	N/A	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A
NUVA NuVasive	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.12%	N/A	42.90%	N/A

Latest NUVA, MASI, TFX, and ITGR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/12/2025	TFX Teleflex	quarterly	$0.34	1.09%	5/20/2025	5/20/2025	6/16/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ITGR Integer	0.78	3.40	2.14
MASI Masimo	0.67	2.17	1.62
NUVA NuVasive	0.50	1.25	0.65
TFX Teleflex	0.44	2.28	1.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ITGR Integer	99.29%
MASI Masimo	85.96%
NUVA NuVasive	N/A
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
ITGR Integer	2.16%
MASI Masimo	9.70%
NUVA NuVasive	0.53%
TFX Teleflex	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ITGR Integer	10,000	34.89 million	34.14 million	Optionable
MASI Masimo	5,600	54.22 million	48.96 million	Optionable
NUVA NuVasive	3,000	52.45 million	52.17 million	Optionable
TFX Teleflex	14,100	44.19 million	43.57 million	Optionable

NUVA, MASI, TFX, and ITGR Headlines

Recent News About These Companies

Teleflex Incorporated (NYSE:TFX) Shares Sold by Robeco Institutional Asset Management B.V.

July 2 at 4:01 AM | marketbeat.com

Teleflex Completes Biotronik Vascular Intervention Business Acquisition

July 1 at 1:48 PM | evtoday.comE

Teleflex closes deal with BIOTRONIK

July 1 at 10:56 AM | seekingalpha.com

Teleflex completes acquisition of Biotronik’s Vascular Intervention business

July 1 at 8:46 AM | massdevice.com

Unified Investment Management Buys New Shares in Teleflex Incorporated (NYSE:TFX)

July 1 at 6:47 AM | marketbeat.com

Teleflex Incorporated Completes Acquisition of BIOTRONIK's Vascular Intervention Business

July 1 at 6:42 AM | quiverquant.comQ

Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business

July 1 at 6:30 AM | globenewswire.com

Bessemer Group Inc. Sells 18,147 Shares of Teleflex Incorporated (NYSE:TFX)

July 1 at 3:56 AM | marketbeat.com

RBA Wealth Management LLC Buys New Shares in Teleflex Incorporated (NYSE:TFX)

June 29, 2025 | marketbeat.com

Teleflex (NYSE:TFX) Stock Rating Lowered by Wall Street Zen

June 29, 2025 | americanbankingnews.com

Teleflex (NYSE:TFX) Downgraded to "Hold" Rating by Wall Street Zen

June 29, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Shares Sold by Marathon Asset Management Ltd

June 28, 2025 | marketbeat.com

Zacks Research Comments on Teleflex's Q2 Earnings (NYSE:TFX)

June 27, 2025 | marketbeat.com

Zacks Research Has Bearish Forecast for Teleflex Q2 Earnings

June 27, 2025 | americanbankingnews.com

5 Insightful Analyst Questions From Teleflex’s Q1 Earnings Call

June 26, 2025 | finance.yahoo.com

What is Zacks Research's Estimate for Teleflex Q2 Earnings?

June 26, 2025 | marketbeat.com

Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching

June 25, 2025 | finance.yahoo.com

Teleflex (NYSE:TFX) Reaches New 1-Year Low - What's Next?

June 23, 2025 | marketbeat.com

2,500 Shares in Teleflex Incorporated (NYSE:TFX) Acquired by Praxis Investment Management Inc.

June 23, 2025 | marketbeat.com

Teleflex Incorporated (NYSE:TFX) Shares Bought by State of Alaska Department of Revenue

June 21, 2025 | marketbeat.com

Wall Street Zen Upgrades Teleflex (NYSE:TFX) to "Buy"

June 21, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUVA, MASI, TFX, and ITGR Company Descriptions

Integer NYSE:ITGR

$121.33 +0.04 (+0.03%)

Closing price 07/2/2025 03:59 PM Eastern

Extended Trading

$121.24 -0.08 (-0.07%)

As of 07/2/2025 04:20 PM Eastern

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Masimo NASDAQ:MASI

$171.34 +2.33 (+1.38%)

Closing price 07/2/2025 04:00 PM Eastern

Extended Trading

$171.34 0.00 (0.00%)

As of 07/2/2025 04:06 PM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

NuVasive NASDAQ:NUVA

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.

Teleflex NYSE:TFX

$121.40 -0.43 (-0.35%)

Closing price 07/2/2025 03:59 PM Eastern

Extended Trading

$122.36 +0.96 (+0.79%)

As of 07/2/2025 07:21 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time